Clinical Trials
29 trialsAn AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum
Fondazione del Piemonte per l'Oncologia
PRESERVE
Angiodynamics, Inc.
AGN-Cogni.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients
Milton S. Hershey Medical Center
Effect of Education to be Provided to Patients to Undergo TURP With Mobile Application on Patient Outcomes
Tarsus University
CYTALUXâ„¢for the Intraoperative Imaging of Prostate Cancer
Indiana University
Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer
City of Hope Medical Center
Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging
Stanford University
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy
National Institutes of Health Clinical Center (CC)
Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy
Mayo Clinic
CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
Masonic Cancer Center, University of Minnesota
CHRU-WCMC
University Hospital, Lille
Hemi-Gland Cryoablation for Prostate Cancer at UCLA
Jonsson Comprehensive Cancer Center
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery
Ohio State University Comprehensive Cancer Center
Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
NRG Oncology
SPARK
University of Sydney
PROSTATEP
University Hospital, Bordeaux
DISRUPT
Icahn School of Medicine at Mount Sinai
Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
Memorial Sloan Kettering Cancer Center
QUANTIB
IRCCS San Raffaele
A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
BioXcel Therapeutics Inc
Nivolumab in Biochemically Recurrent dMMR Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer
Mayo Clinic
Detection of Cancer in Breath Samples by Trained Detection Dogs
SpotitEarly
RF-2018-123683
IRCCS San Raffaele
MP-PET-MRI
IRCCS San Raffaele
PRS-AS
IRCCS San Raffaele
UROPET
University Hospital, Bordeaux
TRAP
Royal Marsden NHS Foundation Trust